This brand name is authorized in Austria, Brazil, Canada
The drug NUBAIN contains one active pharmaceutical ingredient (API):
1
Nalbuphine
UNII ZU4275277R - NALBUPHINE HYDROCHLORIDE
|
Nalbuphine is an opioid with kappa-agonistic and mu-antagonistic properties. Beside the essential agonistic (analgesic) effect nalbuphine has antagonistic effects of about a fourth of nalorfine and ten times of pentazocine. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
NUBAIN Solution for injection | Health Products and Food Branch (CA) | MPI, CA: SPM |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N02AF02 | Nalbuphine | N Nervous system → N02 Analgesics → N02A Opioids → N02AF Morphinan derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Cรขmara de Regulaรงรฃo do Mercado de Medicamentos | Identifier(s): 506712101153413, 506715030057703, 506717040068403 |
Country: CA | Health Products and Food Branch | Identifier(s): 01913980 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.